Patents by Inventor Paolo Puccetti

Paolo Puccetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indole-3-aldehyde for treating dysreactive immune disorders
    Patent number: 10751322
    Abstract: The therapeutic use of bacteria, specifically but not only lactobacilli, which produce indole-3-aldehyde, or directly of indole-3-aldehyde itself, is proposed as a means of prevention and treatment of immune dysreactive disorders in which the hyper-inflammatory or autoimmune component represents the basic element.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: August 25, 2020
    Assignee: Universita′ degli Studi di Perugia
    Inventors: Luigina Romani, Paolo Puccetti, Teresa Zelante, Maurizio Ricci, Stefano Giovagnoli
  • INDOLE-3-ALDEHYDE FOR TREATING DYSREACTIVE IMMUNE DISORDERS
    Publication number: 20160206595
    Abstract: The therapeutic use of bacteria, specifically but not only lactobacilli, which produce indole-3-aldehyde, or directly of indole-3-aldehyde itself, is proposed as a means of prevention and treatment of immune dysreactive disorders in which the hyper-inflammatory or autoimmune component represents the basic element
    Type: Application
    Filed: August 18, 2014
    Publication date: July 21, 2016
    Inventors: Luigina ROMANI, Paolo PUCCETTI, Maria Zelante
  • MICROENCAPSULATION PROCESS OF SERTOLI CELLS, MICROCAPSULES OBTAINED AND USE FOR TREATMENT OF TYPE I DIABETES MELLITUS
    Publication number: 20150044109
    Abstract: An apparatus for production of microcapsules includes a volumetric pump configured to deliver a polysaccaridic suspension through a catching tube. A needle-type element is configured to receive the suspension through the catching tube, and the needle-type element has a button hole opening in a lateral wall thereof and an output hole that outputs the suspension. The button hole opening receives a pressure fluid current. A pressure regulator is coupled to the button hole opening to regulate the pressure fluid current to interrupt a suspension flow and obtain microdroplets of homogeneous size exiting the output hole. The microdroplets are received in a receiving container in a solution including divalent cations or polycationic substances to form a gel such that homogeneous microcapsules are formed.
    Type: Application
    Filed: October 14, 2014
    Publication date: February 12, 2015
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi
  • Microencapsulation process of sertoli cells, microcapsules obtained and use for treatment of type I diabetes mellitus
    Patent number: 8865218
    Abstract: The invention relates to the use of Sertoli cells (SC) microencapsulated into hydrogel-based microcapsules, for the prevention and/or treatment of Type 1 diabetes mellitus (T1DM) and to a process for producing microcapsules, preferably shaped as microspheres.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: October 21, 2014
    Assignee: GH Care, Inc.
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi
  • MICROENCAPSULATION PROCESS OF SERTOLI CELLS, MICROCAPSULES OBTAINED AND THEIR USE FOR PREVENTION AND CURE OF TYPE I DIABETES MELLITUS
    Publication number: 20110250280
    Abstract: The invention relates to the use of Sertoli cells (SC) microencapsulated into hydrogel-based microcapsules, for the prevention and/or treatment of Type 1 diabetes mellitus (T1DM) and to a process for producing microcapsules, preferably shaped as microspheres.
    Type: Application
    Filed: December 18, 2009
    Publication date: October 13, 2011
    Inventors: Riccardo Calafiore, Giovanni Luca, Mario Calvitti, Ennio Becchetti, Paolo Puccetti, Francesca Fallarino, Claudio Nastruzzi